• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Cardiac Implants Market Analysis

    ID: MRFR/MED/5263-CR
    163 Pages
    Rahul Gotadki
    April 2019

    Cardiac Implants Market Research Report Information by Device (Coronary Stents, Prosthetic Heart Valve Devices, & Others), Indication (Arrhythmias, Heart Failure, & Others), End User (Hospitals, Cardiac Care Centers, & Others), and Region - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Cardiac Implants Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Analysis

    In-depth Analysis of Cardiac Implants Market Industry Landscape

    Compression therapy is a clinical intervention that involves applying managed pressure to precise frame components and the usage of clothes like stockings or bandages. The market dynamics of Compression therapy are encouraged by the growing prevalence of chronic diseases, which include venous insufficiency and diabetes. As those situations turn out to be extra enormous, there may be a developing demand for effective and non-invasive treatments like compression therapy to manipulate signs and improve affected persons' effects. The Compression therapy marketplace has accelerated beyond scientific applications to the sports activities and fitness industry. Athletes use compression garments to enhance performance, lessen muscle fatigue, and accelerate restoration. This diversification broadens the client base and influences market dynamics. The developing emphasis on preventive healthcare and well-being developments contributes to the marketplace dynamics. Compression therapy is increasingly diagnosed as a safety measure in opposition to certain situations, attractive to folks who prioritize maintaining the highest quality fitness and well-being. Market dynamics are stimulated by attention campaigns and academic projects highlighting the benefits of Compression therapy. Healthcare professionals and producers interact in efforts to inform both patients and the public about the healing advantages of compression clothes. The rise of e-trade systems has transformed the distribution channels for Compression therapy merchandise. Consumers can now, without difficulty, get entry to compression clothes online due to expanded marketplace competition and the emergence of direct-to-consumer income fashions. The market responds to the developing demand for personalized healthcare answers. Manufacturers are growing customizable compression clothes that cater to character patient desires, considering factors including length, compression stage, and particular clinical conditions. Adherence to regulatory standards and first-class assurance is important within the Compression therapy market. Manufacturers need to follow guidelines to ensure the safety and effectiveness of their products, influencing market dynamics and shaping patron acceptance as true. The globalization of healthcare and increasing admission to scientific treatments globally impact market dynamics. As the focus of compression therapy spreads globally, the marketplace stories enlarge into new areas, using the need to adapt to diverse healthcare landscapes. The effectiveness of compression therapy is predicated on patient compliance, and market dynamics are motivated by demanding situations on this element. Manufacturers and healthcare experts work on growing user-pleasant and comfortable compression clothes to improve adherence to remedy plans. Insurance and compensation rules considerably impact marketplace dynamics. Changes in healthcare policies and the multiplied popularity of Compression therapy as a reimbursable treatment alternative impact the affordability and accessibility of these interventions for sufferers.

    Market Summary

    The Global Cardiac Implants Market is projected to grow significantly from 44.9 USD Billion in 2024 to 125.7 USD Billion by 2035.

    Key Market Trends & Highlights

    Cardiac Implants Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 9.82% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 125.7 USD Billion, reflecting robust growth.
    • In 2024, the market is valued at 44.9 USD Billion, indicating a strong foundation for future expansion.
    • Growing adoption of advanced cardiac implant technologies due to increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 44.9 (USD Billion)
    2035 Market Size 125.7 (USD Billion)
    CAGR (2025-2035) 9.82%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Abbott, Amg International, Edwards Life Sciences Corporation, Braun Melsungen AG, Biotronik, Boston Scientific Corporation, LivaNova PLC, Medtronic PLC, Syncardia Systems, Inc, Terumo Corporation

    Market Trends

    The growth of the cardiac implants industry is driven by factors such as growing geriatric population coupled with the increasing prevalence of cardiac diseases. Generally, the older population is more susceptible to diseases as with aging, the heart and blood vessels become stiff which can lead to conditions such as heart failure, coronary artery disease, and atrial fibrillation, among others.  According to the data published by the Centers for Disease Control and Prevention (CDC) in 2017, about 2.7 to 6.1 million people in the US had atrial fibrillation, a common form of heart arrhythmia.

    However, the high cost of cardiac implants are a risk of injections is likely to affect the growth of the market.

    Cardiac Implants Market Revenue, by End User, 2022 (USD Billion)

     

    Driver:

    Rising Prevalence of Cardiac Disease and Geriatric Population

    The rise in older adults and the rising prevalence of chronic diseases are the major drivers of the cardiac implant devices. Geriatric people are highly susceptible to chronic diseases like cardiovascular diseases, endovascular diseases, orthopedic disorders, and dental disorders, which are having the major need for medical implants. Generally, for aged people, dental disorder was a common problem. Hence with a rise in aged people, demand for tooth loss may increase. At the risk of a patient’s cardiac disorder, most healthcare organizations and hospitals prefer cardiovascular implants to provide artificial control on the patient’s heartbeat.

    Restraint:

    High Cost of Treatment and stringent approval process

    Some cardiac patients may affect infections with implantable pacemakers, which makes them avoid these products. Thus reduces the demand for cardiac implants. The high cost of treatment is also a big burden for the normal ones. Hence the demand for cardiovascular implants growth decreases.

    Opportunities:

    Increase in Awareness and technological advancements

    By increasing the awareness of different types of medical implants among healthcare professionals can boost the growth of the cardiac implants industry. By introducing the new advanced technologies in medical implants, the availability of better medical facilities, a large number of cases with damaged organs caused due to different types of accidents are the opportunities to increase the cardiac implants market share.

    Technology Analysis

    The new advanced technologies in medical implants are expected to increase the growth of the Cardiac Implants Industry.

    Study Objectives -

    To provide detailed information about the Cardiac Implants structure along with various forecast segments and sub-segments.

    To provide the factors that affect the cardiac implants market share growth.

    To analyze the cardiac implants market-based porter’s five force analysis, etc.

    To provide the country-level analysis of the current cardiac implants market size and future prospective.

    To provide country-level analysis of the cardiac monitoring device implants growth by region, device, indication, and end-user.

    To provide a strategic profile of the key players in the market, analyze their core competencies, and draw a landscape of the cardiac implants market growth.

    To track and analyze new product developments, strategic alliances, and research in the cardiac implants market.

    The Global Cardiac Implants Market is poised for growth as advancements in technology and an increasing prevalence of cardiovascular diseases drive demand for innovative therapeutic solutions.

    U.S. Food and Drug Administration (FDA)

    Cardiac Implants Market Market Drivers

    Market Growth Projections

    The Global Cardiac Implants Market Industry is projected to experience substantial growth in the coming years. With a compound annual growth rate (CAGR) of 9.82% anticipated from 2025 to 2035, the market is expected to expand significantly. By 2024, the market is estimated to reach 44.9 USD Billion, and by 2035, it could potentially reach 125.7 USD Billion. This growth trajectory reflects the increasing demand for cardiac implants driven by various factors, including technological advancements, an aging population, and rising healthcare expenditures. The market's expansion indicates a robust future for cardiac health solutions.

    Regulatory Support and Reimbursement Policies

    Supportive regulatory frameworks and favorable reimbursement policies are pivotal in shaping the Global Cardiac Implants Market Industry. Governments and health authorities are increasingly recognizing the importance of cardiac implants in managing heart diseases, leading to streamlined approval processes for new devices. Additionally, comprehensive reimbursement policies facilitate access to these technologies, encouraging healthcare providers to adopt them. This supportive environment fosters innovation and investment in the development of advanced cardiac implants. Consequently, the market is poised for growth, as these factors collectively enhance the accessibility and affordability of cardiac care.

    Increasing Prevalence of Cardiovascular Diseases

    The rising incidence of cardiovascular diseases globally is a primary driver of the Global Cardiac Implants Market Industry. As lifestyle-related factors such as obesity, sedentary behavior, and unhealthy diets continue to escalate, the demand for cardiac implants is likely to increase. For instance, cardiovascular diseases account for approximately 31% of all global deaths, highlighting the urgent need for effective treatment options. This growing health crisis is expected to propel the market, which is projected to reach 44.9 USD Billion in 2024, indicating a robust demand for innovative cardiac solutions.

    Technological Advancements in Implantable Devices

    Technological innovations in implantable cardiac devices are transforming the Global Cardiac Implants Market Industry. Advancements such as bioresorbable stents, leadless pacemakers, and remote monitoring capabilities enhance the efficacy and safety of cardiac implants. These innovations not only improve patient outcomes but also reduce the risk of complications, thereby increasing adoption rates among healthcare providers. The integration of artificial intelligence and machine learning into these devices further personalizes treatment, potentially leading to better management of cardiovascular conditions. As a result, the market is anticipated to experience significant growth, driven by these cutting-edge technologies.

    Aging Population and Increased Healthcare Expenditure

    The global demographic shift towards an aging population is a crucial factor influencing the Global Cardiac Implants Market Industry. Older adults are more susceptible to cardiovascular diseases, necessitating advanced medical interventions such as cardiac implants. Additionally, increased healthcare expenditure in many countries supports the adoption of these technologies. Governments and healthcare systems are investing in innovative treatments to address the growing burden of heart diseases. This trend is expected to contribute to the market's expansion, with projections indicating a growth trajectory that could see the market reach 125.7 USD Billion by 2035.

    Rising Awareness and Preventive Healthcare Initiatives

    Growing awareness regarding cardiovascular health and preventive healthcare initiatives are driving the Global Cardiac Implants Market Industry. Educational campaigns and community outreach programs are informing the public about the risks associated with heart diseases and the benefits of early intervention. This heightened awareness encourages individuals to seek medical advice and treatment, leading to increased demand for cardiac implants. Furthermore, healthcare providers are emphasizing preventive measures, which may result in earlier diagnoses and timely interventions. As a consequence, the market is likely to witness sustained growth as more patients opt for cardiac implants as a preventive measure.

    Market Segment Insights

    Cardiac Implants Indication Insights

    Based on Indication, the global market is segmented into Arrhythmias, myocardial ischemia, acute myocardial infarction, heart failure, and others.

    Cardiac Implants Device Insights

    The cardiac implant devices are segmented into implantable loop recorder, cardiac rhythm management devices, coronary stents, ventricular assist devices, and others.

    Cardiac Implants End-Users Insights

    On the basis of the end-users, market of cardiac implants is segmented into cardiac care centers, ambulatory centers, hospitals,  academic institutes, home care, and others.

    Get more detailed insights about Cardiac Implants Market Research Report - Global Forecast till 2032

    Regional Insights

    Key Companies in the Cardiac Implants Market market include

    Industry Developments

    • Q2 2024: Medtronic receives FDA approval for next-generation Micra AV2 and Micra VR2 leadless pacemakers Medtronic announced that the U.S. FDA has approved its latest Micra AV2 and Micra VR2 leadless pacemakers, expanding options for patients needing cardiac rhythm management devices.
    • Q2 2024: Boston Scientific launches FARAPULSE Pulsed Field Ablation System in Europe Boston Scientific announced the commercial launch of its FARAPULSE Pulsed Field Ablation System for the treatment of atrial fibrillation in select European markets following CE Mark approval.
    • Q1 2024: Edwards Lifesciences receives FDA approval for SAPIEN 3 Ultra RESILIA heart valve Edwards Lifesciences announced U.S. FDA approval of its SAPIEN 3 Ultra RESILIA valve, a next-generation transcatheter heart valve designed to improve durability and patient outcomes.
    • Q2 2024: Abbott launches AVEIR DR dual chamber leadless pacemaker system in the U.S. Abbott announced the U.S. launch of its AVEIR DR dual chamber leadless pacemaker system, the first of its kind to receive FDA approval for treating patients with abnormal heart rhythms.
    • Q1 2024: Biotronik receives CE Mark for BIOMONITOR IV implantable cardiac monitor Biotronik announced it has received CE Mark approval for its BIOMONITOR IV, an implantable cardiac monitor designed for long-term heart rhythm monitoring.
    • Q2 2024: Boston Scientific completes $3.7 billion acquisition of Axonics Boston Scientific finalized its acquisition of Axonics, a company specializing in implantable sacral neuromodulation devices, expanding its portfolio in the cardiac and urology device markets.
    • Q1 2024: Medtronic launches Harmony Transcatheter Pulmonary Valve in Japan Medtronic announced the commercial launch of its Harmony Transcatheter Pulmonary Valve in Japan, following regulatory approval for use in patients with congenital heart disease.
    • Q2 2024: Abbott receives FDA approval for TriClip transcatheter tricuspid valve repair system Abbott announced that the U.S. FDA has approved its TriClip system, the first transcatheter device for repairing the tricuspid heart valve, offering a new treatment option for patients with tricuspid regurgitation.
    • Q1 2024: LivaNova appoints new CEO, Vladimir Makatsaria LivaNova, a global medical technology company specializing in cardiac surgery and neuromodulation, announced the appointment of Vladimir Makatsaria as its new Chief Executive Officer.
    • Q2 2024: Edwards Lifesciences opens new manufacturing facility in Ireland Edwards Lifesciences inaugurated a new manufacturing facility in Limerick, Ireland, to expand production capacity for its transcatheter heart valve technologies.
    • Q1 2024: CardioFocus receives FDA approval for HeartLight X3 Endoscopic Ablation System CardioFocus announced that the U.S. FDA has approved its HeartLight X3 Endoscopic Ablation System for the treatment of atrial fibrillation, enhancing options for minimally invasive cardiac procedures.
    • Q2 2024: Boston Scientific receives FDA approval for WATCHMAN FLX Pro Left Atrial Appendage Closure Device Boston Scientific announced U.S. FDA approval of its WATCHMAN FLX Pro device, designed to reduce stroke risk in patients with non-valvular atrial fibrillation.

    .

    Future Outlook

    Cardiac Implants Market Future Outlook

    The Global Cardiac Implants Market is projected to grow at a 9.82% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditures.

    New opportunities lie in:

    • Develop innovative biocompatible materials for implantable devices.
    • Leverage telemedicine for remote monitoring of cardiac implant patients.
    • Expand into emerging markets with tailored cardiac solutions.

    By 2035, the market is expected to exhibit robust growth, positioning itself as a leader in cardiovascular health solutions.

    Market Segmentation

    Cardiac Implants End-User Outlook

    Cardiac Implants Regional Outlook

    Cardiac Implants Device Type Outlook

    Cardiac Implants Indication Type Outlook

    Report Scope

    Report Attribute/Metric Details
    Market Size 2032 USD 97.13 Billion
    Compound Annual Growth Rate (CAGR) 8.97% (2024-2032)
    Base Year 2023
    Forecast Period 2024-2032
    Historical Data 2019 & 2022
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Device, Indication, End User and Region
    Geographies Covered America, Europe, Asia-Pacific, and the Middle-East & Africa
    Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Abbott (US), Amg International (Germany), Edwards Life Sciences Corporation (US), Braun Melsungen AG (Germany), Biotronik (US), Boston Scientific Corporation (US), LivaNova PLC (UK), Medtronic PLC (US), Syncardia Systems, Inc (Arizona), Terumo Corporation (Japan)
    Key Market Opportunities Increasing awareness and introducing the new advanced technologies
    Key Market Dynamics Rise in older adults and rising prevalence of chronic diseases

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the valuation of the Cardiac Implants Market?

    Cardiac implants market is expected to rise to a valuation of more than USD 97.13 Billion by 2032.

    What is the CAGR of the Cardiac Implants Market?

    The global market is expected to exhibit a strong 8.97% CAGR over the forecast period.

    What is the prime driver for the market?

    The increasing geriatric population and the increasing prevalence of chronic heart conditions are the major drivers for the global cardiac implants market.

    What is the key restraint on the Cardiac Implants Market?

    The high costs of cardiac implants are the key restraint against the global cardiac implants market.

    What is the leading regional segment of the Cardiac Implants Market?

    North America is likely to hold the largest share in the global cardiac implants market.

    1. List of Tables and Figures
      1. TABLE 1 LIST OF ASSUMPTIONS 17
      2. TABLE
      3. 2 GLOBAL CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 35
      4. TABLE
      5. 3 GLOBAL CARDIAC IMPLANTS MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES, BY REGION,
      6. 2022–2030 (USD Billion) 36
      7. TABLE 4 GLOBAL CARDIAC IMPLANTS MARKET
      8. FOR CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 36
      9. TABLE
      10. 5 GLOBAL CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030
      11. (USD Billion) 36
      12. TABLE 6 GLOBAL CARDIAC IMPLANTS MARKET FOR CORONARY
      13. STENTS, BY REGION, 2022–2030 (USD Billion) 37
      14. TABLE 7 GLOBAL
      15. CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion)
      16. 37
      17. TABLE 8 GLOBAL CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE
      18. DEVICES, BY REGION, 2022–2030 (USD Billion) 38
      19. TABLE 9 GLOBAL
      20. CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030
      21. (USD Billion) 39
      22. TABLE 10 GLOBAL CARDIAC IMPLANTS MARKET FOR VENTRICULAR
      23. ASSIST DEVICES, BY REGION, 2022–2030 (USD Billion) 39
      24. TABLE
      25. 11 GLOBAL CARDIAC IMPLANTS MARKET FOR IMPLANTABLE LOOP RECORDER/IMPLANTABLE CARDIAC
      26. MONITOR, BY REGION, 2022–2030 (USD Billion) 40
      27. TABLE 12 GLOBAL
      28. CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 43
      29. TABLE
      30. 13 GLOBAL CARDIAC IMPLANTS MARKET FOR ARRHYTHMIAS, BY REGION, 2022–2030 (USD
      31. Billion) 43
      32. TABLE 14 GLOBAL CARDIAC IMPLANTS MARKET FOR MYOCARDIAL
      33. ISCHEMIA, BY REGION, 2022–2030 (USD Billion) 44
      34. TABLE 15 GLOBAL
      35. CARDIAC IMPLANTS MARKET FOR ACUTE MYOCARDIAL INFARCTION, BY REGION, 2022–2030
      36. (USD Billion) 45
      37. TABLE 16 GLOBAL CARDIAC IMPLANTS MARKET FOR HEART
      38. FAILURE, BY REGION, 2022–2030 (USD Billion) 45
      39. TABLE 17 GLOBAL
      40. CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 49
      41. TABLE
      42. 18 GLOBAL CARDIAC IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD
      43. Billion) 49
      44. TABLE 19 GLOBAL CARDIAC IMPLANTS MARKET FOR CARDIAC CARE
      45. CENTERS, BY REGION, 2022–2030 (USD Billion) 50
      46. TABLE 20 GLOBAL
      47. CARDIAC IMPLANTS MARKET FOR AMBULATORY CENTERS & HOME CARE, BY REGION, 2022–2030
      48. (USD Billion) 50
      49. TABLE 21 GLOBAL CARDIAC IMPLANTS MARKET FOR ACADEMIC
      50. INSTITUTES, BY REGION, 2022–2030 (USD Billion) 51
      51. TABLE 22 GLOBAL
      52. CARDIAC IMPLANTS MARKET, BY REGION, 2022–2030 (USD Billion) 54
      53. TABLE
      54. 23 AMERICAS: CARDIAC IMPLANTS MARKET, BY REGION, 2022–2030 (USD Billion) 55
      55. TABLE
      56. 24 AMERICAS: CARDIAC IMPLANTS MARKET, BY DEVICES, 2022–2030 (USD Billion)
      57. 56
      58. TABLE 25 AMERICAS: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT
      59. DEVICES, BY TYPE, 2022–2030 (USD Billion) 56
      60. TABLE 26 AMERICAS:
      61. CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030
      62. (USD Billion) 57
      63. TABLE 27 AMERICAS: CARDIAC IMPLANTS MARKET FOR CORONARY
      64. STENTS, BY TYPE, 2022–2030 (USD Billion) 57
      65. TABLE 28 AMERICAS:
      66. CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030
      67. (USD Billion) 58
      68. TABLE 29 AMERICAS: CARDIAC IMPLANTS MARKET, BY INDICATION,
      69. 2022–2030 (USD Billion) 58
      70. TABLE 30 AMERICAS: CARDIAC IMPLANTS
      71. MARKET, BY END USER, 2022–2030 (USD Billion) 59
      72. TABLE 31 NORTH
      73. AMERICA: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD Billion) 59
      74. TABLE
      75. 32 NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion)
      76. 60
      77. TABLE 33 NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM
      78. MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 60
      79. TABLE
      80. 34 NORTH AMERICA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY
      81. TYPE, 2022–2030 (USD Billion) 61
      82. TABLE 35 NORTH AMERICA: CARDIAC
      83. IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 61
      84. TABLE
      85. 36 NORTH AMERICA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY
      86. TYPE, 2022–2030 (USD Billion) 62
      87. TABLE 37 NORTH AMERICA: CARDIAC
      88. IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 62
      89. TABLE
      90. 38 NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion)
      91. 63
      92. TABLE 39 US: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030
      93. (USD Billion) 63
      94. TABLE 40 US: CARDIAC IMPLANTS MARKET, BY CARDIAC
      95. RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 64
      96. TABLE
      97. 41 US: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030
      98. (USD Billion) 64
      99. TABLE 42 US: CARDIAC IMPLANTS MARKET FOR CORONARY
      100. STENTS, BY TYPE, 2022–2030 (USD Billion) 64
      101. TABLE 43 US: CARDIAC
      102. IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD
      103. Billion) 65
      104. TABLE 44 US: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030
      105. (USD Billion) 65
      106. TABLE 45 US: CARDIAC IMPLANTS MARKET, BY END USER,
      107. 2022–2030 (USD Billion) 66
      108. TABLE 46 CANADA: CARDIAC IMPLANTS
      109. MARKET, BY DEVICE, 2022–2030 (USD Billion) 66
      110. TABLE 47 CANADA:
      111. CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030
      112. (USD Billion) 67
      113. TABLE 48 CANADA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE
      114. CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 67
      115. TABLE
      116. 49 CANADA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030
      117. (USD Billion) 67
      118. TABLE 50 CANADA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC
      119. HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 68
      120. TABLE
      121. 51 CANADA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion)
      122. 68
      123. TABLE 52 CANADA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030
      124. (USD Billion) 69
      125. TABLE 53 LATIN AMERICA: CARDIAC IMPLANTS MARKET,
      126. BY DEVICE, 2022–2030 (USD Billion) 69
      127. TABLE 54 LATIN AMERICA:
      128. CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030
      129. (USD Billion) 70
      130. TABLE 55 LATIN AMERICA: CARDIAC IMPLANTS MARKET FOR
      131. IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 70
      132. TABLE
      133. 56 LATIN AMERICA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030
      134. (USD Billion) 70
      135. TABLE 57 LATIN AMERICA: CARDIAC IMPLANTS MARKET FOR
      136. PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 71
      137. TABLE
      138. 58 LATIN AMERICA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion)
      139. 71
      140. TABLE 59 LATIN AMERICA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030
      141. (USD Billion) 72
      142. TABLE 60 EUROPE: CARDIAC IMPLANTS MARKET, BY REGION,
      143. 2022–2030 (USD Billion) 73
      144. TABLE 61 EUROPE: CARDIAC IMPLANTS
      145. MARKET, BY DEVICE, 2022–2030 (USD Billion) 74
      146. TABLE 62 EUROPE:
      147. CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030
      148. (USD Billion) 74
      149. TABLE 63 EUROPE: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE
      150. CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 75
      151. TABLE
      152. 64 EUROPE: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030
      153. (USD Billion) 75
      154. TABLE 65 EUROPE: CARDIAC IMPLANTS MARKET FOR PROSTHETIC
      155. HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 76
      156. TABLE
      157. 66 EUROPE: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion)
      158. 76
      159. TABLE 67 EUROPE: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030
      160. (USD Billion) 77
      161. TABLE 68 WESTERN EUROPE: CARDIAC IMPLANTS MARKET,
      162. BY COUNTRY, 2022–2030 (USD Billion) 78
      163. TABLE 69 WESTERN EUROPE:
      164. CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 78
      165. TABLE
      166. 70 WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES,
      167. BY TYPE, 2022–2030 (USD Billion) 79
      168. TABLE 71 WESTERN EUROPE:
      169. CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030
      170. (USD Billion) 79
      171. TABLE 72 WESTERN EUROPE: CARDIAC IMPLANTS MARKET
      172. FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 79
      173. TABLE
      174. 73 WESTERN EUROPE: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY
      175. TYPE, 2022–2030 (USD Billion) 80
      176. TABLE 74 WESTERN EUROPE: CARDIAC
      177. IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 80
      178. TABLE
      179. 75 WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion)
      180. 81
      181. TABLE 76 GERMANY: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030
      182. (USD Billion) 81
      183. TABLE 77 GERMANY: CARDIAC IMPLANTS MARKET, BY CARDIAC
      184. RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 82
      185. TABLE
      186. 78 GERMANY: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE,
      187. 2022–2030 (USD Billion) 82
      188. TABLE 79 GERMANY: CARDIAC IMPLANTS
      189. MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 82
      190. TABLE
      191. 80 GERMANY: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE,
      192. 2022–2030 (USD Billion) 83
      193. TABLE 81 GERMANY: CARDIAC IMPLANTS
      194. MARKET, BY INDICATION, 2022–2030 (USD Billion) 83
      195. TABLE 82 GERMANY:
      196. CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 84
      197. TABLE
      198. 83 FRANCE: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 84
      199. TABLE
      200. 84 FRANCE: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE,
      201. 2022–2030 (USD Billion) 85
      202. TABLE 85 FRANCE: CARDIAC IMPLANTS
      203. MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion)
      204. 85
      205. TABLE 86 FRANCE: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY
      206. TYPE, 2022–2030 (USD Billion) 85
      207. TABLE 87 FRANCE: CARDIAC IMPLANTS
      208. MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion)
      209. 86
      210. TABLE 88 FRANCE: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030
      211. (USD Billion) 86
      212. TABLE 89 FRANCE: CARDIAC IMPLANTS MARKET, BY END
      213. USER, 2022–2030 (USD Billion) 87
      214. TABLE 90 UK: CARDIAC IMPLANTS
      215. MARKET, BY DEVICE, 2022–2030 (USD Billion) 87
      216. TABLE 91 UK: CARDIAC
      217. IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030
      218. (USD Billion) 88
      219. TABLE 92 UK: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE
      220. CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 88
      221. TABLE
      222. 93 UK: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD
      223. Billion) 88
      224. TABLE 94 UK: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART
      225. VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 89
      226. TABLE 95
      227. UK: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 89
      228. TABLE
      229. 96 UK: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 90
      230. TABLE
      231. 97 ITALY: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 90
      232. TABLE
      233. 98 ITALY: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE,
      234. 2022–2030 (USD Billion) 91
      235. TABLE 99 ITALY: CARDIAC IMPLANTS
      236. MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion)
      237. 91
      238. TABLE 100 ITALY: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY
      239. TYPE, 2022–2030 (USD Billion) 91
      240. TABLE 101 ITALY: CARDIAC IMPLANTS
      241. MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion)
      242. 92
      243. TABLE 102 ITALY: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030
      244. (USD Billion) 92
      245. TABLE 103 ITALY: CARDIAC IMPLANTS MARKET, BY END
      246. USER, 2022–2030 (USD Billion) 93
      247. TABLE 104 SPAIN: CARDIAC IMPLANTS
      248. MARKET, BY DEVICE, 2022–2030 (USD Billion) 93
      249. TABLE 105 SPAIN:
      250. CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030
      251. (USD Billion) 94
      252. TABLE 106 SPAIN: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE
      253. CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 94
      254. TABLE
      255. 107 SPAIN: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030
      256. (USD Billion) 94
      257. TABLE 108 SPAIN: CARDIAC IMPLANTS MARKET FOR PROSTHETIC
      258. HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 95
      259. TABLE
      260. 109 SPAIN: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion)
      261. 95
      262. TABLE 110 SPAIN: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030
      263. (USD Billion) 96
      264. TABLE 111 REST OF WESTERN EUROPE: CARDIAC IMPLANTS
      265. MARKET, BY DEVICE, 2022–2030 (USD Billion) 96
      266. TABLE 112 REST
      267. OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES,
      268. BY TYPE, 2022–2030 (USD Billion) 97
      269. TABLE 113 REST OF WESTERN
      270. EUROPE: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030
      271. (USD Billion) 97
      272. TABLE 114 REST OF WESTERN EUROPE: CARDIAC IMPLANTS
      273. MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 97
      274. TABLE
      275. 115 REST OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES,
      276. BY TYPE, 2022–2030 (USD Billion) 98
      277. TABLE 116 REST OF WESTERN
      278. EUROPE: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 98
      279. TABLE
      280. 117 REST OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030
      281. (USD Billion) 99
      282. TABLE 118 EASTERN EUROPE CARDIAC IMPLANTS MARKET,
      283. BY DEVICE, 2022–2030 (USD Billion) 99
      284. TABLE 119 EASTERN EUROPE:
      285. CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030
      286. (USD Billion) 100
      287. TABLE 120 EASTERN EUROPE: CARDIAC IMPLANTS MARKET
      288. FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 100
      289. TABLE
      290. 121 EASTERN EUROPE: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030
      291. (USD Billion) 100
      292. TABLE 122 EASTERN EUROPE: CARDIAC IMPLANTS MARKET
      293. FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 101
      294. TABLE
      295. 123 EASTERN EUROPE: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD
      296. Billion) 101
      297. TABLE 124 EASTERN EUROPE: CARDIAC IMPLANTS MARKET, BY
      298. END USER, 2022–2030 (USD Billion) 102
      299. TABLE 125 ASIA-PACIFIC:
      300. CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD Billion) 103
      301. TABLE
      302. 126 ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion)
      303. 104
      304. TABLE 127 ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM
      305. MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 104
      306. TABLE
      307. 128 ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY
      308. TYPE, 2022–2030 (USD Billion) 105
      309. TABLE 129 ASIA-PACIFIC: CARDIAC
      310. IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 105
      311. TABLE
      312. 130 ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY
      313. TYPE, 2022–2030 (USD Billion) 106
      314. TABLE 131 ASIA-PACIFIC: CARDIAC
      315. IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 106
      316. TABLE
      317. 132 ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion)
      318. 107
      319. TABLE 133 JAPAN: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030
      320. (USD Billion) 107
      321. TABLE 134 JAPAN: CARDIAC IMPLANTS MARKET, BY CARDIAC
      322. RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 108
      323. TABLE
      324. 135 JAPAN: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030
      325. (USD Billion) 108
      326. TABLE 136 JAPAN: CARDIAC IMPLANTS MARKET FOR CORONARY
      327. STENTS, BY TYPE, 2022–2030 (USD Billion) 108
      328. TABLE 137 JAPAN:
      329. CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030
      330. (USD Billion) 109
      331. TABLE 138 JAPAN: CARDIAC IMPLANTS MARKET, BY INDICATION,
      332. 2022–2030 (USD Billion) 109
      333. TABLE 139 JAPAN: CARDIAC IMPLANTS
      334. MARKET, BY END USER, 2022–2030 (USD Billion) 110
      335. TABLE 140 CHINA:
      336. CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 110
      337. TABLE
      338. 141 CHINA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE,
      339. 2022–2030 (USD Billion) 111
      340. TABLE 142 CHINA: CARDIAC IMPLANTS
      341. MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion)
      342. 111
      343. TABLE 143 CHINA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS,
      344. BY TYPE, 2022–2030 (USD Billion) 111
      345. TABLE 144 CHINA: CARDIAC
      346. IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD
      347. Billion) 112
      348. TABLE 145 CHINA: CARDIAC IMPLANTS MARKET, BY INDICATION,
      349. 2022–2030 (USD Billion) 112
      350. TABLE 146 CHINA: CARDIAC IMPLANTS
      351. MARKET, BY END USER, 2022–2030 (USD Billion) 113
      352. TABLE 147 INDIA:
      353. CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 113
      354. TABLE
      355. 148 INDIA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE,
      356. 2022–2030 (USD Billion) 114
      357. TABLE 149 INDIA: CARDIAC IMPLANTS
      358. MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion)
      359. 114
      360. TABLE 150 INDIA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS,
      361. BY TYPE, 2022–2030 (USD Billion) 114
      362. TABLE 151 INDIA: CARDIAC
      363. IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD
      364. Billion) 115
      365. TABLE 152 INDIA: CARDIAC IMPLANTS MARKET, BY INDICATION,
      366. 2022–2030 (USD Billion) 115
      367. TABLE 153 INDIA: CARDIAC IMPLANTS
      368. MARKET, BY END USER, 2022–2030 (USD Billion) 116
      369. TABLE 154 AUSTRALIA:
      370. CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 116
      371. TABLE
      372. 155 AUSTRALIA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY
      373. TYPE, 2022–2030 (USD Billion) 117
      374. TABLE 156 AUSTRALIA: CARDIAC
      375. IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD
      376. Billion) 117
      377. TABLE 157 AUSTRALIA: CARDIAC IMPLANTS MARKET FOR CORONARY
      378. STENTS, BY TYPE, 2022–2030 (USD Billion) 117
      379. TABLE 158 AUSTRALIA:
      380. CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030
      381. (USD Billion) 118
      382. TABLE 159 AUSTRALIA: CARDIAC IMPLANTS MARKET, BY
      383. INDICATION, 2022–2030 (USD Billion) 118
      384. TABLE 160 AUSTRALIA:
      385. CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 119
      386. TABLE
      387. 161 SOUTH KOREA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion)
      388. 119
      389. TABLE 162 SOUTH KOREA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM
      390. MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 120
      391. TABLE
      392. 163 SOUTH KOREA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE,
      393. 2022–2030 (USD Billion) 120
      394. TABLE 164 SOUTH KOREA: CARDIAC IMPLANTS
      395. MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 120
      396. TABLE
      397. 165 SOUTH KOREA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY
      398. TYPE, 2022–2030 (USD Billion) 121
      399. TABLE 166 SOUTH KOREA: CARDIAC
      400. IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 121
      401. TABLE
      402. 167 SOUTH KOREA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion)
      403. 122
      404. TABLE 168 REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY DEVICE,
      405. 2022–2030 (USD Billion) 122
      406. TABLE 169 REST OF ASIA-PACIFIC:
      407. CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030
      408. (USD Billion) 123
      409. TABLE 170 REST OF ASIA-PACIFIC: CARDIAC IMPLANTS
      410. MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion)
      411. 123
      412. TABLE 171 REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR CORONARY
      413. STENTS, BY TYPE, 2022–2030 (USD Billion) 123
      414. TABLE 172 REST
      415. OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY
      416. TYPE, 2022–2030 (USD Billion) 124
      417. TABLE 173 REST OF ASIA-PACIFIC:
      418. CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 124
      419. TABLE
      420. 174 REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030
      421. (USD Billion) 125
      422. TABLE 175 MIDDLE EAST & AFRICA: CARDIAC IMPLANTS
      423. MARKET, BY REGION, 2022–2030 (USD Billion) 126
      424. TABLE 176 MIDDLE
      425. EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion)
      426. 127
      427. TABLE 177 MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY
      428. CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 127
      429. TABLE
      430. 178 MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER,
      431. BY TYPE, 2022–2030 (USD Billion) 128
      432. TABLE 179 MIDDLE EAST &
      433. AFRICA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD
      434. Billion) 128
      435. TABLE 180 MIDDLE EAST & AFRICA: CARDIAC IMPLANTS
      436. MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion)
      437. 129
      438. TABLE 181 MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY
      439. INDICATION, 2022–2030 (USD Billion) 129
      440. TABLE 182 MIDDLE EAST
      441. & AFRICA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion)
      442. 130
      443. TABLE 183 MIDDLE EAST: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030
      444. (USD Billion) 130
      445. TABLE 184 MIDDLE EAST: CARDIAC IMPLANTS MARKET,
      446. BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 131
      447. TABLE
      448. 185 MIDDLE EAST: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE,
      449. 2022–2030 (USD Billion) 131
      450. TABLE 186 MIDDLE EAST: CARDIAC IMPLANTS
      451. MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 131
      452. TABLE
      453. 187 MIDDLE EAST: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY
      454. TYPE, 2022–2030 (USD Billion) 132
      455. TABLE 188 MIDDLE EAST: CARDIAC
      456. IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 132
      457. TABLE
      458. 189 MIDDLE EAST: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion)
      459. 133
      460. TABLE 190 AFRICA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030
      461. (USD Billion) 133
      462. TABLE 191 AFRICA: CARDIAC IMPLANTS MARKET, BY CARDIAC
      463. RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 134
      464. TABLE
      465. 192 AFRICA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE,
      466. 2022–2030 (USD Billion) 134
      467. TABLE 193 AFRICA: CARDIAC IMPLANTS
      468. MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 134
      469. TABLE
      470. 194 AFRICA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE,
      471. 2022–2030 (USD Billion) 135
      472. TABLE 195 AFRICA: CARDIAC IMPLANTS
      473. MARKET, BY INDICATION, 2022–2030 (USD Billion) 135
      474. TABLE 196
      475. AFRICA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 136
      476. 16
    2. List of Tables and Figures
      1. FIGURE 1 GLOBAL CARDIAC IMPLANTS MARKET: MARKET STRUCTURE
      2. 18
      3. FIGURE 2 RESEARCH PROCESS OF MRFR 20
      4. FIGURE 3 TOP-DOWN
      5. & BOTTOM-UP APPROACHES 23
      6. FIGURE 4 MARKET DYNAMICS: ANALYSIS OF
      7. THE GLOBAL CARDIAC IMPLANTS MARKET 25
      8. FIGURE 5 VALUE CHAIN: GLOBAL
      9. CARDIAC IMPLANTS MARKET 29
      10. FIGURE 6 PORTER’S FIVE FORCES ANALYSIS:
      11. GLOBAL CARDIAC IMPLANTS MARKET 30
      12. FIGURE 7 GLOBAL CARDIAC IMPLANTS
      13. MARKET, BY DEVICE, 2022 AND 2030 (USD Billion) 34
      14. FIGURE 8 GLOBAL
      15. CARDIAC IMPLANTS MARKET SHARE, BY DEVICE, 2022 (%) 34
      16. FIGURE 9 GLOBAL
      17. CARDIAC IMPLANTS MARKET, BY INDICATION, 2022 AND 2030 (USD Billion) 42
      18. FIGURE
      19. 10 GLOBAL CARDIAC IMPLANTS MARKET SHARE, BY INDICATION, 2022 (%) 42
      20. FIGURE
      21. 11 GLOBAL CARDIAC IMPLANTS MARKET, BY END USER, 2022 AND 2030 (USD Billion) 48
      22. FIGURE
      23. 12 GLOBAL CARDIAC IMPLANTS MARKET SHARE, BY END USER, 2022 (%) 48
      24. FIGURE
      25. 13 GLOBAL CARDIAC IMPLANTS MARKET, BY REGION, 2022 AND 2030 (USD Billion) 53
      26. FIGURE
      27. 14 GLOBAL CARDIAC IMPLANTS MARKET SHARE, BY REGION, 2022 (%) 53
      28. FIGURE
      29. 15 AMERICAS: CARDIAC IMPLANTS MARKET, BY REGION, 2022 (%) 55
      30. FIGURE
      31. 16 NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022 (%) 59
      32. FIGURE
      33. 17 EUROPE: CARDIAC IMPLANTS MARKET, BY REGION, 2022 (%) 73
      34. FIGURE
      35. 18 WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022 (%) 77
      36. FIGURE
      37. 19 ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022 (%) 103
      38. FIGURE
      39. 20 MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY REGION, 2022 (%) 126
      40. FIGURE
      41. 21 GLOBAL CARDIAC IMPLANTS MARKET, MARKET SHARE ANALYSIS 2022 (%) 138

    Cardiac Implants Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials